Loading…
← CockpitCompetitor Analysis › DOCS Doximity, Inc. Class AOpen in the cockpit ↗

Doximity, Inc. Class ADOCSCompetitor analysis, valuation and peers

United States · USD·Information Technology›Packaged Software

Operates a digital professional network for US physicians, offering telehealth tools, hiring and pharma marketing services.

Momentum leader 92
Mkt cap
$5.47B
US dollars, full cap
Free float
96%
of shares outstanding
$/day
$77.7M
20-day average traded
Fwd P/E
21.2×
forward earnings
ROIC−WACC
+50.6 pp
WACC 11.5%
Hurdle
-9 pp
Req g minus delivered
Next earnings
85 days
11 Feb 2027
Close · USD$30.67
1D-1.4%
1W-7.7%
1M-8.0%
3M+18.2%
6M+59.2%
YTD-30.7%
1Y-38.2%
ATR %4.7%
Beta0.59
52w lowhigh40.8% off high

What Doximity does

Operates a digital professional network for US physicians, offering telehealth tools, hiring and pharma marketing services.

Doctors use the network free, and pharmaceutical companies pay annual contracts to reach them with ads and educational content, so income depends on drugmakers' marketing budgets and on how many physicians visit. Health systems also pay to recruit. Free tools such as telehealth keep physicians returning.

Products and services

  • Physician professional network/news feed
  • Telehealth/virtual visit tools
  • Pharma marketing to physicians
  • Physician hiring/recruitment tools

Customers

  • Physicians (free network users)
  • Pharmaceutical companies (advertisers)
  • Health systems

Where it sits in the supply chain

  • Information technology
  • Healthcare IT
  • Physician professional network…

What could go right

  • Growing pharma digital marketing spend on the platform
  • Physician engagement/monetization growth

What could go wrong

  • Pharma marketing budget cyclicality
  • Physician engagement/network growth deceleration

Moat: narrow (network effects, data, installed base). Large share of US physicians on the network gives strong network effects and pharma advertiser demand.

Headquarters: San Francisco, California, United States · Founded: 2011 · Employees: 880

Named competitors

Doximity at a glance

Size Doximity (DOCS) is a United States Information Technology company (Packaged Software) with a market value of $5.47B, the 1112th largest of 3,085 United States companies the cockpit tracks. Shares closed at $30.67 on 18 Nov 2026.

Performance Over six months the shares gained 59.2%, against +10.4% for the median peer and -2.2% for the United States market (cap-weighted) — 5th highest of 19 in its peer set.

Growth Revenue grew 6.5% over the last twelve months (peer median +13.5%); the operating margin is 26.7% (peer median 12.8%).

Valuation It trades at 21.2× forward earnings against a peer median of 18.7× (8th most expensive of 18).

Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +26%, so the hurdle is -9 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 50.6 points above its cost of capital (11.5% WACC).

Short interest Short interest is 5.5% of the free float (30 Oct 2026).

Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012515017521 May 202621 Aug 202618 Nov 2026DOCS 154Peer median 111
Six months, rebased to 100: Doximity against the median of its 20 peers (local-currency closes).

Doximity financials

Reported figures in USD; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$662M$645M$570M$475M$419M
Revenue growth—+13%+20%+13%—
Gross profit$566M$575M$515M$425M$366M
EBITDA$201M$236M$241M$183M$138M
Net income$140M$196M$223M$148M$113M
Free cash flow$297M$318M$267M$178M$178M
Capital expenditure$8.96M$8.96M$6.53M$5.80M$6.18M
Total debt$9.15M$10.2M$12.4M$14.5M$15.6M

Quarterly statements and history in the cockpit →

Doximity competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%-20%0%+20%0020AUTOOTEXSEZLDLBACIWWAY600570BILLVRNS600845301236TOI002558NIQBB0100RNGDOCS6-month return →1-month return →
Up and to the right = strong over both horizons. Doximity is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%0×50×100×AUTOOTEXSEZLDLBACIWWAY600570VRNS600845301236TOI002558BBDOCSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Doximity is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%AUTOOTEXSEZLDLBACIWWAY600570BILLVRNS600845OCTVTOI002558NIQBBRNGDOCSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Doximity is the large dot.

Doximity competitors and peer comparison

Head to head with its named competitors (DOCS vs VEEV vs IQV)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Doximity DOCS$5.47B+59%+6%27%21.2×17.0%
Veeva Systems VEEV$44.9B+68%+16%30%28.7×23.1%
Iqvia IQV$42.5B+50%+9%14%18.7×16.8%

How Doximity compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Doximity against its 20 peers (data as of 18 Nov 2026)
MeasureDOCSPeer medianRank in peer set
1-month return-8.0%-4.5%9th lowest of 21
6-month return+59.2%+10.4%5th highest of 19
Distance from 52-week high-40.8%-27.2%5th lowest of 21
Revenue growth (TTM)+6.5%+13.5%7th lowest of 21
Operating margin26.7%12.8%4th highest of 21
Forward P/E21.2×18.7×8th most expensive of 18
Growth the price implies (Req g, 7 yrs)17.0%14.5%8th most demanding of 17
Growth delivered (Del g)+25.5%+15.3%5th highest of 17
Hurdle (Req g minus delivered)-8.6 pp-4.4 pp7th least demanding of 17
ROIC minus cost of capital+50.6 pp+0.3 pphighest of 21
EV / EBITDA23.6×14.5×3rd most expensive of 13
Net debt / EBITDA-3.5×0.6×2nd least indebted of 14

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Doximity DOCSUnited States$5.47B+59%+6%27%21.2×17.0%+25.5%
SenseTime 0020.HKHong Kong$5.53B-43%+31%-51%n/an/an/a
AutoStore AUTO.OLNorway$5.39B+16%+27%32%27.1×19.2%+27.0%
Open Text OTEX.TOCanada$5.55B+5%-1%23%6.0×-6.8%+10.8%
Sezzle SEZLUnited States$5.36B+116%+39%42%23.7×27.4%+50.3%
Dolby Laboratories DLBUnited States$5.32B+5%+5%23%12.9×4.9%+2.1%
ACI Worldwide ACIWUnited States$5.30B+22%+2%15%18.7×13.7%+6.3%
Waystar WAYUnited States$5.30B+43%+21%24%15.3×7.6%+16.0%
Hundsun Technologies 600570.SSChina$5.66B-21%-5%9%27.8×33.5%+7.0%
BILL BILLUnited States$5.67B+72%+7%7%16.1×26.2%+47.3%
Varonis Systems VRNSUnited States$5.68B+58%+18%-26%136.4×23.7%+16.3%
Shanghai Baosight Software 600845.SSChina$5.71B-28%+11%10%30.0×6.2%+1.4%
Octave Intelligence OCTVUnited States$5.72Bn/a+1%20%15.4×17.5%+1.3%
iSoftStone Information Technology (Group) 301236.SZChina$5.20B-12%+13%0%106.6×n/an/a
Topicus.com TOI.VCanada$5.79B0%+24%16%20.6×-0.6%+26.5%
Giant Network 002558.SZChina$5.16B-39%+105%48%8.9×-3.7%+17.9%
NIQ Global Intelligence NIQUnited States$5.13B+103%+9%10%13.2×3.1%+14.6%
Beijing Deepzero Technology 2947.HKHong Kong$5.13Bn/a+31%1%n/an/an/a
BlackBerry BB.TOCanada$5.02B+44%+14%16%40.5×33.8%-8.6%
MiniMax 0100.HKHong Kong$5.00B-84%+159%-407%n/an/an/a
RingCentral RNGUnited States$6.01B+64%+5%9%13.2×15.3%+16.3%

Questions

Who are Doximity's main competitors?
Named competitors: Veeva Systems (VEEV), IQVIA Holdings (IQV), Epocrates (Athenahealth) (private or unlisted), OptimizeRx (private or unlisted). The cockpit's measured peer set (industry) also includes SenseTime (0020.HK), AutoStore (AUTO.OL), Open Text (OTEX.TO), Sezzle (SEZL), Dolby Laboratories (DLB), ACI Worldwide (ACIW).
Is Doximity expensive compared with its peers?
On forward p/e it trades at 21.2× against a peer median of 18.7×, 8th most expensive of 18 in its peer set. For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +26%, so the hurdle is -9 pp: the price already allows for a slowdown.
How has Doximity stock performed?
Over six months to 18 Nov 2026 the shares returned +59.2% against +10.4% for the median peer; over one year -38.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.